Preliminary results of hyperthermic intraperitoneal intraoperative chemotherapy as an adjuvant in resectable pancreatic cancer

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Tentes, Antonios Apostolos K ^a   Kyziridis, Dimitrios ^a   Kakolyris, Stylianos ^b   Pallas, Nicolaos ^a   Zorbas, Georgios ^a   Korakianitis, Odysseas ^a   Mavroudis, Christos ^a   Courcoutsakis, Nicolaos ^b   Prasopoulos, Panos ^b  

^a Didimotichon General Hospital   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; MALE; MORBIDITY; NEUTROPENIA; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; SEPSIS; TREATMENT OUTCOME;

EID: 84862296293     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/506571     Document Type: Article

References (25)

1. Bramhall S. R., Allum W. H., Jones A. G., Allwood A., Cummins C., Neoptolemos J. P., Treatment and survival in 13 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study British Journal of Surgery 1995 82 1 111 115
2. Jemal A., Thomas A., Murray T., Thun M., Cancer statistics Ca-A Cancer Journal for Clinicians 2002 52 3 23 47
3. Beger H. G., Rau B., Gansauge F., Leder G., Schwarz M., Poch B., Pancreatic cancerlow survival rates Deutsches Arzteblatt 2008 105 14 255 262
4. Lim J. E., Chien M. W., Earle C. C., Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients Annals of Surgery 2003 237 1 74 85 (Pubitemid 36622320)
5. Cameron J. L., Riall T. S., Coleman J., Belcher K. A., One thousand consecutive pancreaticoduodenectomies Annals of Surgery 2006 244 1 10 15 (Pubitemid 44297442)
6. Schneider G., Siveke J. T., Eckel F., Schmid R. M., Pancreatic cancer: basic and clinical aspects Gastroenterology 2005 128 6 1606 1625 (Pubitemid 40692555)
7. Geer R. J., Brennan M. F., Cameron J., Sonneland J., Reber H. A., Langer B., Warshaw A. L., Bell R. H., Way L. W., Prognostic indicators for survival after resection of pancreatic adenocarcinoma American Journal of Surgery 1993 165 1 68 73 (Pubitemid 23289365)
8. Nitecki S. S., Sarr M. G., Colby T. V., van Heerden J. A., Long-term survival after resection for ductal adenocarcinoma of the pancreas: is it really improving? Annals of Surgery 1995 221 1 59 66
9. Birkmeyer J. D., Warshaw A. L., Finlayson S. R. G., Grove M. R., Tosteson A. N. A., Relationship between hospital volume and late survival after pancreaticoduodenectomy Surgery 1999 126 2 178 183 (Pubitemid 29382778)
10. Kalser M. H., Ellenberg S. S., Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Archives of Surgery 1985 120 8 899 903 (Pubitemid 15040883)
11. Klinkenbijl J. H., Jeekel J., Sahmoud T., Van Pel R., Couvreur M. L., Veenhof C. H., Arnaud J. P., Gonzalez D. G., De Wit L. T., Hennipman A., Wils J., Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group Annals of Surgery 1999 230 6 776 784 (Pubitemid 30191812)
12. Neoptolemos J. P., Stocken D. D., Friess H., A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer The New England Journal of Medicine 2004 350 12 1200 1210 (Pubitemid 38339364)
13. Hsu C. C., Herman J. M., Corsini M. M., Winter J. M., Callister M. D., Haddock M. G., Cameron J. L., Pawlik T. M., Schulick R. D., Wolfgang C. L., Laheru D. A., Farnell M. B., Swartz M. J., Gunderson L. L., Miller R. C., Adjuvant chemoradiation for pancreatic adenocarcinoma: the johns hopkins hospital-mayo clinic collaborative study Annals of Surgical Oncology 2010 17 4 981 990
14. Warshaw A. L., Fernndez-del Castillo C., Pancreatic carcinoma The New England Journal of Medicine 1992 326 7 455 465
15. Sugarbaker P., Sugarbaker P., Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology Peritoneal Carcinomatosis: Principles and Practice of Management 1996 Boston, Mass, USA Kluwer Academic 79 100
16. Sugarbaker P. H., Peritonectomy procedures Annals of Surgery 1995 221 1 29 42
17. Jacquet P., Sugarbaker P. H., Sugarbaker P., Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis Peritoneal Carcinomatosis: Principles and Practice of Management 1996 Boston, Mass, USA Kluwer Academic 369 374
18. Dedrick R. L., Theoretical and experimental bases of intraperitoneal chemotherapy Seminars in Oncology 1985 12 3, supplement 4 1 6 (Pubitemid 16222022)
19. Oettle H., Post S., Neuhaus P., Gellert K., Langrehr J., Ridwelski K., Schramm H., Fahlke J., Zuelke C., Burkart C., Gutberlet K., Kettner E., Schmalenberg H., Weigang-Koehler K., Bechstein W. O., Niedergethmann M., Schmidt-Wolf I., Roll L., Doerken B., Riess H., Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial Journal of the American Medical Association 2007 297 3 267 277 (Pubitemid 46143304)
20. Ridwelski K., Meyer F., Hribaschek A., Kasper U., Lippert H., Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurence of peritoneal carcinomatosis Journal of Surgical Oncology 2002 79 1 10 16 (Pubitemid 34049539)
21. Gamblin T. C., Egorin M. J., Zuhowski E. G., Lagattuta T. F., Herscher L. L., Russo A., Libutti S. K., Alexander H. R., Dedrick R. L., Bartlett D. L., Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas Cancer Chemotherapy and Pharmacology 2008 62 4 647 653 (Pubitemid 352009239)
22. Pestieau S. R., Stuart O. A., Chang D., Jacquet P., Sugarbaker P. H., Pharmacokinetics of intraperitoneal gemcitabine in a rat model Tumori 1998 84 6 706 711 (Pubitemid 29086532)
23. Sugarbaker P. H., Mora J. T., Carmignani P., Stuart O. A., Yoo D., Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy Oncologist 2005 10 2 112 122 (Pubitemid 40261950)
24. Sabbatini P., Aghajanian C., Leitao M., Venkatraman E., Anderson S., Dupont J., Dizon D., O'Flaherty C., Bloss J., Chi D., Spriggs D., Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II trial Clinical Cancer Research 2004 10 9 2962 2967 (Pubitemid 38619671)
25. Speyer J. L., Sugarbaker P. H., Collins J. M., Dedrick R. L., Klecker R. W. Jr., Myers C. E., Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans Cancer Research 1981 41 1916 1922 (Pubitemid 11114596)